Quick HCV care plus peer support boosts treatment uptake in drug users

NCT ID NCT04677153

Completed Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 15 times

Summary

This study tested two strategies to treat hepatitis C in people who use drugs and are in an opioid treatment program. One group got fast treatment with a peer mentor who had been cured of HCV, while the other group got the usual referral to an outside clinic. The goal was to see which approach helped more people start and finish their HCV treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Johns Hopkins University

Baltimore, Maryland, 21287, United States
University Health Network Toronto

Toronto, Ontario, M5G 2C4, Canada
University of Alabama

Birmingham, Alabama, 35294, United States
University of California, San Francisco

San Francisco, California, 94143, United States

Conditions

Explore the condition pages connected to this study.

HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF